Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Bear Biotech catalogue
SS-31 / Elamipretide
Mitochondria-targeting tetrapeptide research material
- Mitochondrial bioenergetics
- Cardiolipin
- Muscle research
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is SS-31 / Elamipretide?
SS-31, also known as elamipretide, is a mitochondria-targeting tetrapeptide studied for interactions with mitochondrial membranes and cardiolipin-associated bioenergetics. Unlike many experimental peptides, it has progressed into human clinical programmes, making mitochondrial function and cellular-energy research its central scientific story. Human findings concern defined elamipretide formulations and do not establish equivalence for generic research material.
Human trials; approved-product context exists for a specific formulation
Research focus
Key research areas
SS-31 research: mitochondria-targeted peptide biology
SS-31, also called elamipretide, is a mitochondria-targeting tetrapeptide associated with cardiolipin. Human studies concern defined formulations that are not equivalent to generic material. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- Mitochondrial bioenergetics
- Cardiolipin
- Muscle research
Representative primary research
Representative research
A randomised placebo-controlled trial evaluated elamipretide in primary mitochondrial myopathy.
- Elamipretide in Individuals With Primary Mitochondrial Myopathy: the MMPOWER-3 trial ↗ Original controlled research on the exact compound.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- SS-31 / Elamipretide
- Research category
- Mitochondria-targeting tetrapeptide research material
- Evidence position
- Human trials; approved-product context exists for a specific formulation
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
How does the proposed SS-31 and cardiolipin interaction frame Elamipretide research?
SS-31 is studied for interactions with cardiolipin-associated mitochondrial membranes. That proposed relationship frames experiments on membrane organisation, respiration and cellular bioenergetics.
Which mitochondrial readouts are used in SS-31 muscle models?
Muscle models can measure mitochondrial respiration, ATP-linked activity, oxidative-phosphorylation efficiency and related bioenergetic capacity. Results remain specific to the tissue model, formulation and protocol.
Why must defined Elamipretide trial formulations be separated from generic SS-31 material?
Human programmes and the approved-product context concern defined Elamipretide formulations. Generic SS-31 research material is not automatically equivalent in formulation, quality or evidentiary status.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.